¼¼°èÀÇ ÀüÀå À¯Àüü ÇÕ¼º ½ÃÀå
Whole Genome Synthesis
»óǰÄÚµå : 1796054
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 378 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,245,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,736,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÀüÀå À¯Àüü ÇÕ¼º ¼¼°è ½ÃÀåÀº 2030³â±îÁö 208¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 54¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÀüÀå À¯Àüü ÇÕ¼º ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 25.3%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 208¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¼ÒÇÁÆ®¿þ¾î ¹× ¼­ºñ½º ±¸¼º¿ä¼Ò´Â CAGR 27.7%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 150¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼Ò¸ðǰ ºÎ¹®Àº ºÐ¼® ±â°£ µ¿¾È¿¡ CAGR 19.7%ÀÇ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 15¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 33.8%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÀüÀå À¯Àüü ÇÕ¼º ½ÃÀåÀº 2024³â¿¡ 15¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ 2024³âºÎÅÍ 2030³â±îÁö 33.8%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 52¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 20.0%¿Í 22.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 21.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÀüÀå À¯Àüü ÇÕ¼º ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÀüÀå À¯Àüü ÇÕ¼ºÀº ÇÕ¼º»ý¹°ÇÐÀÇ ÃÖÀü¼±À» ¾î¶»°Ô ÀçÁ¤ÀÇÇϰí Àִ°¡?

ÀüÀå À¯Àüü ÇÕ¼ºÀº ±âÁ¸ DNA¸¦ º¯ÇüÇÏ´Â °ÍÀÌ ¾Æ´Ñ, À¯Àüü Àüü¸¦ óÀ½ºÎÅÍ ¼³°è ¹× ±¸ÃàÇÒ ¼ö ÀÖ¾î ÇÕ¼º»ý¹°Çп¡¼­ °¡Àå Çõ½ÅÀûÀÎ ±â´É Áß Çϳª·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À¿¬·á »ý»ê¿¡¼­ Áúº´ ÀúÇ×¼º, ȯ°æ Á¤È­±îÁö ƯÁ¤ ±â´ÉÀ» ¼öÇàÇÏ´Â ¸ÂÃãÇü ¼³°è »ý¹°À» Á¶¸³ÇÒ ¼ö ÀÖ°Ô µÈ °ÍÀÔ´Ï´Ù. ÀÌ ±â¼úÀº ½ÇÇè½Ç¿¡¼­ ±ä DNA °¡´ÚÀ» ÇÕ¼ºÇÏ¿© ¼÷ÁÖ ¼¼Æ÷¿¡ »ðÀÔÇÒ ¼ö ÀÖ´Â ±â´É¼º ¿°»öü·Î Á¶¸³ÇÏ´Â ±â¼úÀÔ´Ï´Ù. ÀϹÝÀûÀ¸·Î À¯ÀüüÀÇ ÀϺθ¦ ÆíÁýÇÏ´Â ±âÁ¸ÀÇ À¯ÀüÀÚ ÀçÁ¶ÇÕ°ú ´Þ¸®, ÀüÀå À¯Àüü ÇÕ¼ºÀº À¯ÀüÀÚ ±¸Á¶¸¦ ¿ÏÀüÈ÷ ¸ÂÃãÈ­ÇÒ ¼ö Àֱ⠶§¹®¿¡ »ý¹°ÇÐÀû ±â´ÉÀ» Àü·Ê ¾øÀÌ Á¦¾îÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ »ê¾÷, Á¦¾à, ³ó¾÷ÀÇ ¿ëµµ¿¡ ¸Â´Â ÇÕ¼º ¼¼Æ÷¸¦ ¸¸µé ¼ö ÀÖ´Â °¡´É¼ºÀÌ ³Ð¾îÁý´Ï´Ù. ¿¬±¸ÆÀÀº ÀÌ¹Ì ÃÖ¼ÒÇÑÀÇ »ý¸íü¸¦ ¿¬±¸Çϰí, À¯ÀüÀÚÀÇ º»ÁúÀ» ÀÌÇØÇϰí, ¼¼Æ÷ »ý¸íÀÇ °æ°è¸¦ ޱ¸Çϱâ À§ÇØ ¹ÚÅ׸®¾Æ¿Í È¿¸ðÀÇ À¯Àüü¸¦ ÇÕ¼ºÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÇÕ¼º ½Ã½ºÅÛÀº ½Å¾à Å×½ºÆ®, Èñ±Í »ýüºÐÀÚ »ý»ê, º¹ÀâÇÑ Áúº´ ¸ðµ¨¸µÀ» À§ÇÑ Ç÷§Æû ¿ªÇÒµµ Çϰí ÀÖ½À´Ï´Ù. DNA ÇÕ¼º ºñ¿ëÀÌ °è¼Ó ³·¾ÆÁö°í Á¶¸³ ±â¼úÀÌ ´õ¿í È¿À²ÀûÀ¸·Î ¹ßÀüÇÔ¿¡ µû¶ó, ÀüÀå À¯Àüü ÇÕ¼ºÀº »ý¸í°úÇÐ Çõ½ÅÀÇ Ãʼ®ÀÌ µÉ °ÍÀ̸ç, Áö±Ý±îÁö À̷п¡ ¸Ó¹°·¯ ÀÖ´ø »õ·Î¿î ´É·ÂÀ» ¹ßÈÖÇÒ ¼ö ÀÖ°Ô µÉ °ÍÀÔ´Ï´Ù.

±â¼ú ¹ßÀüÀÌ À¯Àüü ÇÕ¼ºÀÇ È¿À²¼º°ú Á¤È®¼ºÀ» ¾î¶»°Ô °¡¼ÓÈ­Çϰí Àִ°¡?

±Þ¼ÓÇÑ ±â¼ú Çõ½ÅÀº ÀüÀå À¯Àüü ÇÕ¼ºÀÇ ´É·ÂÀ» Çâ»ó½ÃÄÑ ÇÁ·Î¼¼½º¸¦ ´õ ºü¸£°í, ´õ Á¤È®Çϰí, Á¡Á¡ ´õ È®Àå °¡´ÉÇÏ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù. È¿¼Ò ÇÕ¼º ¹× ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ±â¹Ý ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå »ý»ê°ú °°Àº °í󸮷® DNA ÇÕ¼º ±â¼úÀÇ ¹ßÀüÀ¸·Î ¿¬±¸ÀÚµéÀº ¿À·ùÀ²À» ÁÙÀ̰í ó¸® ½Ã°£À» ´ÜÃàÇÏ¿© ±ä DNA ¼­¿­À» »ý¼ºÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ±é½¼ ¾î¼Àºí¸®(Gibson assembly), ÇüÁúÀüȯ °ü·Ã ÀçÁ¶ÇÕ°ú °°Àº ÀÚµ¿ ÀçÁ¶ÇÕ ¹æ¹ýÀº ÀÛÀº DNA Á¶°¢À» ´õ Å« À¯Àüü ±¸Á¶·Î ¿¬°áÇÏ´Â È¿À²À» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ÄÚµ·ÀÇ »ç¿ëÀ» ÃÖÀûÈ­Çϰí, Æúµù ÆÐÅÏÀ» ¿¹ÃøÇϰí, À¯ÀüÀû ¾ÈÁ¤¼ºÀ» º¸ÀåÇÏ´Â »ý¹°Á¤º¸ÇÐ µµ±¸·Î º¸¿ÏµÇ¾î º¸´Ù ±â´ÉÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ÇÕ¼º À¯Àüü¸¦ ¸¸µé ¼ö ÀÖ°Ô ÇÕ´Ï´Ù. ¸Ó½Å·¯´×°ú ÀΰøÁö´ÉÀÇ ÅëÇÕÀº À¯ÀüÀÚ »óÈ£ÀÛ¿ë°ú ´ë»ç °æ·ÎÀÇ °Åµ¿À» ¿¹ÃøÇÏ¿© ¼³°è ´Ü°è¸¦ ´õ¿í Á¤±³ÇÏ°Ô ¸¸µé°í, À¯Àü°øÇп¡¼­ ÈçÈ÷ ¹ß»ýÇÏ´Â ½ÃÇàÂø¿À¸¦ ÁÙÀ̰í ÀÖ½À´Ï´Ù. ǰÁú °ü¸®µµ ȹ±âÀûÀ¸·Î °³¼±µÇ¾úÀ¸¸ç, Â÷¼¼´ë ½ÃÄö¼­´Â ¼÷ÁÖ »ý¹°¿¡ µµÀÔÇϱâ Àü¿¡ ÇÕ¼ºµÈ À¯ÀüüÀÇ Á¤È®¼º°ú ¹«°á¼ºÀ» °ËÁõÇϱâ À§ÇØ ÀÏ»óÀûÀ¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º¥Ä¡Å¾ ÇÕ¼º Ç÷§Æû°ú ÀÚµ¿È­ ·Îº¿ ½Ã½ºÅÛÀº ½ÇÇè½Ç 󸮷®À» Çâ»ó½ÃÄÑ Çмú ¹× »ê¾÷ ½ÇÇè½Ç ¸ðµÎ ÀûÀº ÀÚ¿øÀ¸·Î ´ë±Ô¸ð À¯Àüü ÇÁ·ÎÁ§Æ®¸¦ Ž»öÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ´õ ¸¹Àº ¿¬±¸Àڵ鿡°Ô À¯Àüü ÇÕ¼º¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ³ÐÈú »Ó¸¸ ¾Æ´Ï¶ó, ¿¡³ÊÁö, ³ó¾÷, °Ç°­ µîÀÇ ºÐ¾ß¿¡¼­ ½Ç¿ëÈ­µÇ´Â ÇÕ¼º »ý¹°ÀÇ »ó¾÷Àû ½ÇÇö °¡´É¼ºÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù.

ÀüÀå À¯Àüü ÇÕ¼ºÀÇ ¼ö¿ä¸¦ ÁÖµµÇÏ´Â ÁÖ¿ä »ê¾÷ ºÐ¾ß´Â ¹«¾ùÀΰ¡?

ÀüÀå À¯Àüü ÇÕ¼ºÀÇ ½Ç¿ëÀûÀÎ ÀÀ¿ëÀº ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ ºü¸£°Ô È®´ëµÇ°í ÀÖÀ¸¸ç, °¢ ºÐ¾ß´Â ÇÕ¼ºÀ¯Àüü¸¦ Ȱ¿ëÇÏ¿© º¹ÀâÇÑ ¹®Á¦¸¦ ÇØ°áÇÏ°í »õ·Î¿î ±â´ÉÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. Á¦¾à ¾÷°è¿¡¼­´Â ¸ÂÃãÇü À¯Àüü¸¦ ÀÌ¿ëÇØ ¹Ì»ý¹°À» ¸¶ÀÌÅ©·ÎÆÑÅ丮·Î ÀÛµ¿½ÃÄÑ Èñ±ÍÇÑ Ãµ¿¬ È­ÇÕ¹°, ¹ÙÀÌ¿À½Ã¹Ð·¯, Â÷¼¼´ë Ç×»ýÁ¦ µîÀ» »ý»êÇϰí ÀÖ½À´Ï´Ù. ³ó¾÷ ºÐ¾ß¿¡¼­´Â ÇØÃæ ÀúÇ×¼º, °¡¹³ ÀúÇ×¼º, °í¼öÀÍ ÀÛ¹° °èÅëÀ» °³¹ßÇϱâ À§ÇØ ÇÕ¼º À¯Àüü ¿¬±¸°¡ ÁøÇàµÇ°í ÀÖÀ¸¸ç, ±âÈĺ¯È­¿Í ¼¼°è Àα¸ Áõ°¡¿¡ Á÷¸éÇÑ ½Ä·® ¾Èº¸¿¡ ´ëÇÑ ÇØ°áÃ¥À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À ¿¡³ÊÁö ºÐ¾ß¿¡¼­´Â ¹ÙÀÌ¿À¸Å½º¸¦ Àç»ý °¡´ÉÇÑ ¿¬·á¿Í È­ÇÐÁ¦Ç°À¸·Î È¿À²ÀûÀ¸·Î ÀüȯÇϰí È­¼® ÀÚ¿ø¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ÁÙÀ̱â À§ÇØ ÇÕ¼º ¹Ì»ý¹°ÀÇ Á¶Á¤ÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ȯ°æ ºÐ¾ß·ÎÀÇ ÀÀ¿ëÀ¸·Î´Â ¿À¿°¹°Áú ºÐÇØ, Æó±â¹° ÀçȰ¿ë, ÀÌ»êȭź¼Ò °Ý¸® µî Áö¼Ó°¡´É¼º ¸ñÇ¥ ´Þ¼º¿¡ ±â¿©ÇÏ´Â »ý¹°ÀÇ °³¹ßÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÇÕ¼ºÀ¯Àüü´Â ¹é½Å °³¹ß¿¡¼­µµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ¹ÙÀÌ·¯½º º¤ÅÍ¿Í º¸Á¶Á¦¸¦ Á¤¹ÐÇÏ°Ô Á¦¾îÇÏ¿© È¿´É°ú ¾ÈÀü¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. Çаè¿Í ¿¬±¸¼Ò´Â ¶ÇÇÑ ÇÕ¼º À¯Àüü¸¦ ÀÌ¿ëÇÏ¿© ÃÖ¼ÒÇÑÀÇ ¼¼Æ÷¸¦ ¸¸µé¾î »ý¸í°ú »ý¹°ÇÐÀû ÀÚ±âÁ¶Á÷È­ÀÇ ±âº» ¿ä°Ç¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ ¾ò°íÀÚ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ¿ìÁÖ°³¹ß »ê¾÷¿¡¼­µµ ¿Ü°è ȯ°æ¿¡¼­ÀÇ »ý¸í À¯Áö ½Ã½ºÅÛÀ̳ª ÀÚ¿ø »ý¼º¿¡ Ȱ¿ëµÉ ¼ö ÀÖ´Â ÇÕ¼º»ý¹°ÇÐÀ» ¿¬±¸Çϰí ÀÖ½À´Ï´Ù. À¯Àüü ÇÕ¼ºÀÇ ±¤¹üÀ§ÇÑ À¯¿ë¼º°ú Çõ½Å °¡´É¼ºÀ¸·Î ÀÎÇØ À¯Àüü ÇÕ¼ºÀº °úÇÐÀû ޱ¸¿Í ½ÇÁ¦ ¹®Á¦ ÇØ°á ¸ðµÎ¿¡¼­ ºÐ¾ß¸¦ ÃÊ¿ùÇÏ¿© ÇÙ½ÉÀûÀÎ µµ±¸°¡ µÇ¾ú½À´Ï´Ù.

À¯Àüü ÇÕ¼ºÀÇ ¼¼°è È®ÀåÀ» ÃËÁøÇÏ´Â ½ÃÀå ¼¼·Â°ú Àü·«Àû µ¿ÇâÀº ¹«¾ùÀϱî?

ÀüÀå À¯Àüü ÇÕ¼º ¼¼°è ½ÃÀåÀº °úÇÐÀû ¾ß¸Á, »ê¾÷°èÀÇ ¼ö¿ä, Àü·«Àû ÅõÀÚ°¡ °áÇÕÇÏ¿© À¯Àü°øÇÐÀÇ ±Ô¸ð¿Í ¹üÀ§¸¦ º¯È­½Ã۰í ÀÖ½À´Ï´Ù. DNA ÇÕ¼º ºñ¿ëÀÇ °¨¼Ò´Â ¾î¼Àºí¸® ±â¼ú ¹× °ËÁõ ±â¼úÀÇ ¹ßÀü°ú ÇÔ²² ÁøÀÔÀ庮À» ³·Ãç ´õ ¸¹Àº Á¶Á÷ÀÌ ÇÕ¼º À¯Àüü ÇÁ·ÎÁ§Æ®¿¡ Âü¿©ÇÒ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù. »ý¸í°øÇÐ Çõ½ÅÀ» À§ÇÑ Á¤ºÎ ÀÚ±Ý Áö¿ø ÇÁ·Î±×·¥Àº ÇÕ¼º»ý¹°ÇÐÀÇ ÇѰ踦 ¶Ù¾î³Ñ±â À§ÇÑ Çй®Àû, »ê¾÷Àû ³ë·ÂÀ» Áö¿øÇϰí ÀÖÀ¸¸ç, º¥Ã³ ijÇÇÅаú »ý¸í°øÇÐ ±â¾÷ÀÇ ¹Î°£ ÅõÀÚ´Â »ó¾÷È­¸¦ °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©µµ ÇÕ¼º»ý¹°Çп¡ ´ëÀÀÇÒ ¼ö ÀÖµµ·Ï Á¡Â÷ ÁøÈ­Çϰí ÀÖÀ¸¸ç, º¸´Ù ¸íÈ®ÇÑ °¡À̵å¶óÀÎÀ» Á¦°øÇϰí Åõ¸í¼º°ú ¾ÈÀü¼º Æò°¡¸¦ ÅëÇØ »çȸ·ÎºÎÅÍ ½Å·Ú¸¦ ½×¾Æ°¡°í ÀÖ½À´Ï´Ù. Çаè, ½ºÅ¸Æ®¾÷, ±âÁ¸ »ý¸í°úÇÐ ±â¾÷ °£ÀÇ Çù·Â °­È­´Â À¯Àüü ÇÕ¼º ´É·ÂÀÌ Á¤±³ÇØÁö°í ´Ù¾çÇÑ »ç¿ë »ç·Ê¿¡ Àû¿ëµÉ ¼ö ÀÖ´Â °ß°íÇÑ Çõ½Å »ýŰ踦 Á¶¼ºÇϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À ÆÄ¿îµå¸®¿Í Àü¿ë ÇÕ¼º ½ÇÇè½ÇÀÇ ÃâÇöÀº Àü ¼¼°èÀûÀ¸·Î °í󸮷® ¹× ºñ¿ë È¿À²ÀûÀÎ À¯Àüü ¿£Áö´Ï¾î¸µÀ» Áö¿øÇÏ´Â ÁýÁß Çãºê¸¦ Çü¼ºÇϰí ÀÖ½À´Ï´Ù. ÁöÀûÀç»ê±Ç Àü·« ¶ÇÇÑ »ó¾÷Àû °¡Ä¡°¡ ÀÖ´Â »õ·Î¿î »ý¹°, ¹æ¹ý, ¹è¿­ÀÇ Æ¯Ç㸦 Ãß±¸ÇÏ´Â Á¶Á÷¿¡ ÀÇÇØ ½ÃÀå ¿ªÇÐÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù. µ¿½Ã¿¡ Àΰø»ý¸í âÁ¶¸¦ µÑ·¯½Ñ À±¸®Àû ³íÀïÀÌ Á¶»ç °úÁ¦¿Í »çȸÀû µµÀÔ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Áß¿äÇÑ ´ëÈ­¸¦ Ã˹ßÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÈûµéÀÌ ¼ö·ÅµÇ¸é¼­ ÀüÀå À¯Àüü ÇÕ¼ºÀÌ Â÷¼¼´ë »ý¸í°øÇÐ ¼Ö·ç¼ÇÀÇ º¯ÇõÀû ¿ä¼Ò·Î ¶°¿À¸£¸é¼­ ¿ªµ¿ÀûÀÌ°í ¹Ì·¡ÁöÇâÀûÀÎ ½ÃÀåÀÌ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

±¸¼º¿ä¼Ò(¼ÒÇÁÆ®¿þ¾î ¹× ¼­ºñ½º ±¸¼º¿ä¼Ò, ¼Ò¸ðǰ ±¸¼º¿ä¼Ò, ±â±â ±¸¼º¿ä¼Ò), ¿ëµµ(¸ÂÃãÇü ÀÇ·á ¿ëµµ, ³ó¾÷ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ¿ëµµ, ÇÕ¼º»ý¹°ÇÐ ¿ëµµ, »ê¾÷ ¿ëµµ, ±âŸ ¿ëµµ), ÃÖÁ¾»ç¿ëÀÚ(Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷ ÃÖÁ¾»ç¿ëÀÚ, Áø´Ü ¿¬±¸¼Ò ÃÖÁ¾»ç¿ëÀÚ, Çмú ¹× ¿¬±¸±â°ü ÃÖÁ¾»ç¿ëÀÚ, ¼öŹ¿¬±¸±â°ü ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Whole Genome Synthesis Market to Reach US$20.8 Billion by 2030

The global market for Whole Genome Synthesis estimated at US$5.4 Billion in the year 2024, is expected to reach US$20.8 Billion by 2030, growing at a CAGR of 25.3% over the analysis period 2024-2030. Software & Service Component, one of the segments analyzed in the report, is expected to record a 27.7% CAGR and reach US$15.0 Billion by the end of the analysis period. Growth in the Consumables Component segment is estimated at 19.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 33.8% CAGR

The Whole Genome Synthesis market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2030 trailing a CAGR of 33.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 20.0% and 22.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 21.3% CAGR.

Global Whole Genome Synthesis Market - Key Trends & Drivers Summarized

How Is Whole Genome Synthesis Redefining the Frontiers of Synthetic Biology?

Whole genome synthesis is emerging as one of the most transformative capabilities in synthetic biology, enabling scientists to design and construct entire genomes from scratch rather than modifying existing DNA. This advancement marks a significant leap forward in biological engineering, as researchers now have the ability to assemble custom-designed organisms that perform specific functions, ranging from biofuel production to disease resistance and environmental cleanup. The technique involves synthesizing long strands of DNA in a laboratory setting and assembling them into functional chromosomes that can be inserted into host cells. Unlike traditional genetic modification, which typically involves editing small segments of a genome, whole genome synthesis allows for the complete customization of genetic architecture, offering unprecedented control over biological functions. This opens up possibilities for creating synthetic cells tailored for industrial, pharmaceutical, and agricultural applications. Research groups are already synthesizing bacterial and yeast genomes to study minimal life forms, understand gene essentiality, and explore the boundaries of cellular life. These synthetic systems also serve as platforms for testing new drugs, producing rare biomolecules, and modeling complex diseases. As costs of DNA synthesis continue to decline and assembly techniques become more efficient, whole genome synthesis is positioned to become a cornerstone of innovation in life sciences, unlocking new capabilities that were previously confined to theory.

How Are Technological Advances Accelerating the Efficiency and Accuracy of Genome Synthesis?

Rapid technological innovations are propelling the capabilities of whole genome synthesis, making the process faster, more accurate, and increasingly scalable. Advances in high-throughput DNA synthesis techniques, such as enzymatic synthesis and microarray-based oligonucleotide production, are allowing researchers to generate long DNA sequences with reduced error rates and shorter turnaround times. Automated assembly methods, including Gibson assembly and transformation-associated recombination, are improving the efficiency of stitching together smaller DNA fragments into larger genomic constructs. These technologies are complemented by bioinformatics tools that optimize codon usage, predict folding patterns, and ensure genetic stability, enabling the creation of more functional and reliable synthetic genomes. The integration of machine learning and artificial intelligence is further refining the design phase by predicting gene interactions and metabolic pathway behavior, which reduces the trial-and-error typically associated with genetic engineering. Quality control has also seen dramatic improvements, with next-generation sequencing being routinely used to verify the accuracy and integrity of synthesized genomes before they are introduced into host organisms. Moreover, benchtop synthesis platforms and automated robotic systems are increasing laboratory throughput, enabling both academic and industrial labs to explore large-scale genome projects with fewer resources. These advances are not only expanding the accessibility of genome synthesis to a wider range of researchers but are also accelerating the commercial viability of synthetic organisms for practical use in sectors like energy, agriculture, and health.

What Key Applications Are Driving Demand for Whole Genome Synthesis Across Industries?

The practical applications of whole genome synthesis are expanding rapidly across a variety of sectors, each leveraging synthetic genomes to solve complex challenges and introduce new capabilities. In the pharmaceutical industry, custom genomes are being used to produce rare natural compounds, biosimilars, and next-generation antibiotics by engineering microbes to act as microfactories. The agricultural sector is exploring synthetic genomes to develop pest-resistant, drought-tolerant, and high-yield crop strains, offering solutions to food security in the face of climate change and growing global populations. In the field of bioenergy, synthetic microorganisms are being tailored to efficiently convert biomass into renewable fuels and chemicals, reducing dependence on fossil resources. Environmental applications include the development of organisms that can degrade pollutants, recycle waste, or sequester carbon dioxide, contributing to sustainability goals. Additionally, synthetic genomes are playing a critical role in vaccine development, where precise control over viral vectors and adjuvants enhances efficacy and safety. Academic institutions and research labs are also utilizing synthetic genomes to create minimal cells that provide insights into the fundamental requirements for life and biological self-organization. Even the space exploration industry is investigating synthetic biology for potential use in life-support systems and resource generation in extraterrestrial environments. The broad utility and transformative potential of genome synthesis are making it a central tool in both scientific exploration and real-world problem-solving across disciplines.

What Market Forces and Strategic Trends Are Fueling the Global Expansion of Genome Synthesis?

The global market for whole genome synthesis is being fueled by a combination of scientific ambition, industrial demand, and strategic investment that together are transforming the scale and scope of genetic engineering. The falling cost of DNA synthesis, along with advancements in assembly and verification technologies, is lowering barriers to entry and enabling more organizations to engage in synthetic genome projects. Government funding programs aimed at biotechnology innovation are supporting academic and industrial efforts to push the boundaries of synthetic biology, while private investment from venture capital and biotech firms is accelerating commercialization. Regulatory frameworks are gradually evolving to accommodate synthetic biology, providing clearer guidelines and fostering public trust through transparency and safety assessments. Increased collaboration between academia, startups, and established life sciences companies is fostering a robust innovation ecosystem where genome synthesis capabilities are refined and applied to diverse use cases. The emergence of biofoundries and dedicated synthesis labs is creating centralized hubs that support high-throughput, cost-effective genome engineering on a global scale. Intellectual property strategies are also shaping market dynamics, as organizations seek to patent novel organisms, methods, and sequences that have commercial value. At the same time, ethical discussions around the creation of synthetic life are prompting important conversations that influence research agendas and societal adoption. These converging forces are building a dynamic, forward-looking market where whole genome synthesis stands as a transformative driver of next-generation biotechnological solutions.

SCOPE OF STUDY:

The report analyzes the Whole Genome Synthesis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software & Service Component, Consumables Component, Instrument Component); Application (Personalized Medicine Application, Agricultural Biotechnology Application, Synthetic Biology Application, Industrial Application, Other Applications); End-User (Pharma & Biotech Companies End-User, Diagnostic Laboratories End-User, Academic & Research Institutes End-User, Contract Research Organizations End-User)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â